Three distinct data streams are pointing in the same direction on HAL heading into October earnings. Options positioning is at its most bullish in 20 months. The cost to borrow has crashed to near zero. And retail attention has spiked sharply above its recent baseline.
The put-call ratio on Halliburton hit 0.59 on September 29, within a whisker of its 52-week low of 0.5941. That is 1.47 standard deviations below the 20-day mean of 0.72. In plain terms, traders have been stripping out downside hedges. The direction of travel has been consistent: the PCR stood above 0.80 through most of August and has fallen steadily since mid-September. With earnings scheduled for October 20, the shift suggests the options market is not bracing for a repeat of July's 5.9% post-results selloff.
The cost to borrow fell 61% in one week to 0.11%, the lowest level in months. For a stock with share availability at the ceiling of ORTEX's scale, this is less a squeeze signal and more a statement: there is essentially no conviction-driven demand to be short HAL right now. Short interest sits at 4.2% of free float, modest for an energy-services name, and has barely moved in a week. Lenders are easing terms because the demand simply is not there.
Wikipedia views and ORTEX stock page traffic for Halliburton combined to produce a z-score of 3.0 against the stock's own 90-day average as of September 28. That is an unusually sharp spike in retail attention. The dataset tracks attention, not revenue or fundamentals, but a reading three standard deviations above baseline in the two weeks before earnings is worth flagging alongside the options shift.
UBS raised its price target on HAL to $42 on September 14, keeping a Neutral rating, after cutting it in July post-results. The consensus target sits at $43.44, against a closing price of $31.54 on September 29. That is a large gap. The stock has dropped 12.8% over the past month and 4% in the past week, broadly in line with peers: PTEN fell 5.3% and NBR dropped 7.4% over the same stretch. Sector pressure, not stock-specific deterioration, appears to be driving the pullback.
All insider sales in the past 90 days were executed under pre-arranged 10b5-1 plans and carry limited signalling weight.
See the live data behind this article on ORTEX.
Open HAL on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
